Lokavant to Present Next-Generation Causal AI’s Impact on Clinical Trial Feasibility at DPHARM 2024 Innovations Conference
NEW YORK – Lokavant, the clinical trial intelligence platform company, today announced that Aaron Mackey, PhD, Lokavant Senior Vice President of AI and Development, will be speaking at DPHARM 2024 (Philadelphia, PA) on Tuesday, September 17 at 12:05 pm. Mackey will highlight the next-generation form of artificial intelligence, Causal AI, and how it can optimize clinical trial feasibility assessments and help trial sponsors determine the next best course … Continue reading Lokavant to Present Next-Generation Causal AI’s Impact on Clinical Trial Feasibility at DPHARM 2024 Innovations Conference